4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-032476
Chief Commercial Officer sold 17,000 shares at an average $134.78 ($2,291,221)
- Chief Commercial Officer acquired 17,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CRUTCHFIELD BRADFORD · Chief Commercial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-12 | Exercise or conversion : show line 1 in the form | +17,000 | $1.16 | $19,720 | 51,608 | D |
| 2021-05-12 | Sale : show line 2 in the form | −5,123 | $133.86 | $685,759 | 46,485 | D |
| 2021-05-12 | Sale : show line 3 in the form | −7,875 | $134.70 | $1,060,759 | 38,610 | D |
| 2021-05-12 | Sale : show line 4 in the form | −2,702 | $135.74 | $366,781 | 35,908 | D |
| 2021-05-12 | Sale : show line 5 in the form | −1,200 | $136.80 | $164,164 | 34,708 | D |
| 2021-05-12 | Sale : show line 6 in the form | −100 | $137.57 | $13,757 | 34,608 | D |
| Open-market sales · 17,000 sh · avg $134.78 · $2,291,221 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-05-12 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −17,000 | $1.16 | 2027-02-03 | 17,000 | 545,000 | D |
Loading xslF345X03/doc4.xml…